Q2 2020 Holdings
Filed 2020-08-14 | 54 holdings | $429.2M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2020-11-13) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | ADR | 04351P101 | $265.9M | 1,797,745 | 61.9% |
| Crinetics Pharmaceuticals Inc(CRNX) | Common | 22663K107 | $40.6M | 2,316,628 | 9.5% |
| Arcutis Biotherapeutics Inc(ARQT) | Common | 03969K108 | $39.0M | 1,289,360 | 9.1% |
| Arrowhead Pharmaceuticals Inc(ARWR) | Common | 04280A100 | $24.9M | 576,505 | 5.8% |
| Celldex Therapeutics Inc(CLDX) | Common | 15117B202 | $20.8M | 1,600,000 | 4.8% |
| Codexis, Inc(CDXS) | Common | 192005106 | $17.0M | 1,493,903 | 4.0% |
| Aurinia Pharmaceuticals Inc.(AUPH) | Common | 05156V102 | $8.1M | 500,732 | 1.9% |
| Black Diamond Therapeutics Inc(BDTX) | Common | 09203E105 | $6.3M | 150,349 | 1.5% |
| Atricure Inc(ATRC) | Common | 04963C209 | $2.9M | 64,573 | 0.7% |
| Aclaris Therapeutics, Inc.(ACRS) | Common | 00461U105 | $2.7M | 1,647,214 | 0.6% |
| Legend Biotech Corp Sponsored(LEGN) | SPONSORED ADS | 52490G102 | $151.3K | 3,555,007 | 0.0% |
| New Frontier Health Corp | Ord Shs | G6461G106 | $118.4K | 14,300,000 | 0.0% |
| Genetron Holdings Ltd | ADS | 37186H100 | $76.5K | 6,339,860 | 0.0% |
| Passage Bio Inc | Common | 702712100 | $60.9K | 2,229,587 | 0.0% |
| Amyris, Inc(AMRSEUR) | Common | 03236M200 | $43.5K | 10,181,472 | 0.0% |
| Sinovac Biotech Ltd.(SVA) | SHS | P8696W104 | $38.2K | 5,900,000 | 0.0% |
| Iveric Bio Inc(OPHTEUR) | Common | 46583P102 | $30.4K | 5,966,527 | 0.0% |
| Kiniksa Pharmaceuticals | Common | G5269C101 | $29.3K | 1,151,622 | 0.0% |
| Avadel Pharmaceuticals PLC | ADR | 05337M104 | $28.5K | 3,526,093 | 0.0% |
| Kadmon Holdings Inc(KDMN) | Common | 48283N106 | $27.4K | 5,347,768 | 0.0% |
| Zymeworks Inc | Common | 98985W102 | $26.5K | 734,161 | 0.0% |
| Sierra Oncology, Inc | Common | 82640U107 | $23.2K | 1,917,074 | 0.0% |
| Immunovant Inc(IMVT)A | Common | 45258J102 | $19.5K | 800,000 | 0.0% |
| Insmed Inc(INSM) | Common | 457669307 | $19.5K | 800,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | Common | 77313F106 | $18.0K | 860,648 | 0.0% |
| KalVista Pharmaceuticals Inc.(KALV) | Common | 483497103 | $17.9K | 1,476,796 | 0.0% |
| Zogenix Inc | Common | 98978L204 | $17.8K | 658,523 | 0.0% |
| Eiger BioPharmaceuticals Inc(CLDNEUR) | Common | 28249U105 | $17.2K | 1,791,257 | 0.0% |
| Kura Oncology Inc(KURA) | Common | 50127T109 | $17.1K | 1,050,000 | 0.0% |
| Myokardia Inc | Common | 62857M105 | $15.3K | 158,310 | 0.0% |
| Akero Therapeutics Inc(AKRO) | Common | 00973Y108 | $14.7K | 591,169 | 0.0% |
| Sage Therapeutics Inc(SG7) | Common | 78667J108 | $14.3K | 343,179 | 0.0% |
| Calliditas Therapeutics AB | SPONSORED ADS | 13124Q106 | $13.5K | 580,000 | 0.0% |
| Homology Medicines, Inc. | Common | 438083107 | $13.3K | 875,696 | 0.0% |
| Aduro Biotech Inc(ADROEUR) | Common | 00739L101 | $11.8K | 5,118,560 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | Common | 517125100 | $10.3K | 799,662 | 0.0% |
| Zai Lab Limited(ZLAB) | ADR | 98887Q104 | $10.0K | 122,107 | 0.0% |
| IGM Biosciences Inc(1K0) | Common | 449585108 | $8.7K | 119,480 | 0.0% |
| Matinas Biopharma Hldgs Inc | Common | 576810105 | $8.7K | 11,279,323 | 0.0% |
| Kala Pharmaceuticals, Inc. | Common | 483119103 | $8.3K | 786,883 | 0.0% |
| Verastem Inc | Common | 92337C104 | $8.0K | 4,639,535 | 0.0% |
| Orchard Therapeutics plc | ADS | 68570P101 | $8.0K | 1,325,736 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | Common | 23257D103 | $7.3K | 2,089,356 | 0.0% |
| Verona Pharma PLC(VRNA) | ADS | 925050106 | $7.0K | 1,492,951 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | Common | 816212104 | $6.4K | 2,255,781 | 0.0% |
| Menlo Therapeutics Inc. | Common | 586858102 | $6.3K | 3,643,824 | 0.0% |
| Revolution Medicines Inc(RVMD) | Common | 76155X100 | $6.3K | 199,518 | 0.0% |
| Tricida, Inc.(1T7) | Common | 89610F101 | $4.8K | 174,764 | 0.0% |
| MEI Pharma Inc | Common | 55279B202 | $4.5K | 1,082,080 | 0.0% |
| Avrobio Inc | Common | 05455M100 | $4.4K | 253,625 | 0.0% |